Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 04/16 03:01:49 pm
298.48 USD   +3.61%
3h ago NASDAQ 100 MOVERS : Lltc, yhoo
2d ago REGENERON PHARMACEUTICALS : Yale University Assigned Patent
5d ago REGENERON PHARMACEUTICALS : to Report First Quarter 2014 Financial and Oper..
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/10/2014 04/11/2014 04/14/2014 04/15/2014 04/16/2014 Date
293.62(c) 288.36(c) 290.01(c) 288.08(c) 298.48 Last
1 461 391 1 197 536 768 491 1 100 448 723 792 Volume
-4.13% -1.79% +0.57% -0.67% +3.61% Change
More quotes
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Biotechnology
Calendar
05/08Earnings Release
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 670 M
EBIT 2014 992 M
Net income 2014 605 M
Finance 2014 1 534 M
Yield 2014 -
Sales 2015 3 351 M
EBIT 2015 1 492 M
Net income 2015 863 M
Finance 2015 2 869 M
Yield 2015 -
PER 2014 61,92
PER 2015 40,40
EV / Sales 2014 10,3x
EV / Sales 2015 7,79x
Capitalization 28 980 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
3h ago NASDAQ 100 MOVERS : Lltc, yhoo
2d ago REGENERON PHARMACEUTICALS : Yale University Assigned Patent
5d ago REGENERON PHARMACEUTICALS : to Report First Quarter 2014 Financial and Operating..
6d ago REGENERON PHARMACEUTICALS : Announces Initiative for STEM Education in Hudson Va..
6d ago REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Report Positive Results With ..
7d ago REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
04/09 NASDAQ 100 MOVERS : Isrg, regn
04/08 REGENERON PHARMACEUTICALS : Introduces Initiative for STEM Education in Hudson V..
04/08 REGENERON PHARMACEUTICALS : Launches Initiative for STEM Education in Hudson Val..
04/04 Momentum names may see more pain
04/04 REGENERON PHARMACEUTICALS : Robert A. Ingram Elected to Regeneron Board of Direc..
04/04 REGENERON PHARMACEUTICALS : Announces Initiative for STEM Education in Hudson Va..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
EPS Revisions
Regeneron Pharmaceuticals  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF